This action might not be possible to undo. Are you sure you want to continue?
EMERGENCY DRUGS FOR CARDIAC DISORDERS EMERGENCY DRUGS FOR SHOCK
EMERGENCY DRUGS FOR NEUROSURGICAL DISORDERS
EMERGENCY DRUGS FOR HYPERTENSIVE
uncorrected hypovolemia. narrow-angle glaucoma. renal disease. SE: Cardiac dysrrythmias. I: A narcotic agent used to treat CHEST PAIN associated with an AMI. Thirst. hypotension. Tachycardia. Hypotension ATROPINE SULFATE A: To increase heart rate by inhibiting the action of the vagus nerve. Tachycardia. . MORPHINE SULFATE A: Dilates venous vessels. epilepsy. pregnancy. CI: Hypersensitivity. Mydriasis. Myocardial Restlessness. anastomoses SE: Respiratory distress. Urinary retention. I: Treatment of choice for ANGINA PECTORIS (chest pain) & MYOCARDIAL INFARCTION (heart attack). reduces the workload on the heart. CI: Hypersensitivity.NITROGLYCERIN A: Dilates coronary arteries and improves blood flow. SE: Hypotension. Anxiety. I: Treatment for significant BRADYCARDIA (slow heart rate) & some types of HEART BLOCK (AV block at nodal level). CI: Hypersensitivity. tachycardia. ischemia.
SE: Transient. CI: With poison. . Chest pain. I: Treatment of NARROW COMPLAEX PAROXYSMAL SUPRAVENTRICULAR TACHCARDIA (PSVT) is alternative to adenosine in clients with normal blood pressure and adequate left ventricular function. Flushing. & restores normal rhythm in clients with PSVT. Wolff-Parkinson-White syndrome and heart failure. with refractory hemodynamically significant VERAPAMIL ( Isoptin ) A: It slows conduction (negative chronotropic) through the heart and has negative inotropic and vasodilating effects.or drug-related tachycardia. ADENOSINE A: Slows impulse conduction through the heart’s atrioventricular node. Ventricular ectopy. CI: Simultaneous use of calcium channel blockers and beta-blockers. interrupts dysrhythmia-producing reentry pathways. Bradycardia. clients with sick sinus syndrome. I: First-line drug of choice to treat PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT). preexisting heart block or sick sinus syndrome in the client without a pacemaker. second.ISOPROTERENOL A: To increase heart rate I: Given to client BRADYCARDIA.and third-degree heart block. except those with functioning pacemakers.
Heart failure. Treat VENTRICULAR DYSRHYTMIAS (irregular heart beats).or third-degree AV block. VENTTRICULAR TACHYCARDIA. preexisting heart block or sick sinus syndrome in the client without a pacemaker. CI: Hypersensitivity advanced atrioventricular block. CI: Severe sinus-node dysfunction. pulse less. CI: Simultaneous use of calcium channel blockers and beta-blockers. I: Treat PSVT. PSVT refractory to adenosine. LIDOCAINE A: Decreases automaticity. cardiac conduction defects. CAUTION: Liver disease. muscle twitching and . hearing impairment. SE: Hypotension. Elderly. Wolff-Parkinson-White syndrome and heart failure. and calcium channels. AMIODARONE A: It has alpha. SE: Lidocaine toxicity such as confusion.and beta-adrenergic blocking effects and acts on sodium. myocardial depression.DILTIAZEM ( Cardizel ) A: To slow the ventricular response rate in arterial fibrillation or flutter. hemodynamically stable ventricular tachycardia. I: Treatment of LIFE-THREATENING DYSRHYTHMIAS & CARDIAC ARREST. second. and VENTRICULAR FIBRILLATION. ventricular tachycardia and ventricular fibrillation. potassium. ventricular rate control in atrial fibrillation and for pharmacologic treatment of atrial fibrillation. hypersensitivity. drowsiness. I: Drug of choice for PREMATURE VENTRICULAR CONTRACTIONS. increases electrical threshold of ventricle. Bradycardia.
CARDIAC ARREST associated with HYPOMAGNESEMIA (low serum magnesium level). . Heart block. Cardiac arrest. I: Drug of choice for the treatment of TORSADES DE POINTES. and LIFE-THREATENING VENTRICULAR DYSRHYTHMIAS from digitalis toxicity. but anticonvulsant mechanism is unknown. MAGNESIUM SULFATE A: May decrease acetylcholine released by nerve impulses.PROCAINAMIDE A: An antidysrhythmic agent. Indicated for clients with REFRACTORY VENTRICULAR TACHYCARDIA. I: For VENTRICUALR TACHYCARDIA. CI: Patients with heart block or myocardial damage. PVCs. REFRACTORY VENTRICULAR FIBRILLATION. & RAPID SUORAVENTRICULAR DYSRHYTHMIAS unresponsive to adenosine. SE: Severe hypotension. an unusual polymorphic ventricular tachycardia often associated with prolonged Q-T interval. Rhythm disturbances. CI: Clients with torsades de pointes.
and beta-adrenergic effects. CI: Responsive clients who have coronary artery disease (CAD). & VENTRIBULAR FIBRILLATION. .EPINEPHRINE A: A catecholamine with alpha. To improve PERFUMOSION OF THE HEART & BRAIN in CARDIAC ARREST STATES. VASOPRESSIN A: It increases coronary artery perfusion during cardiopulmonary resuscitation (CPR) & to exhibit vasopressors effects. ASYSTOLE. I: Treatment for VENTRICULAR FIBRILLATION that is refractory to defibrillation. that is. I: Indicated to clients with PROFOUND BRADYCARDIA & HYPOTENSION. clients with CAD who are not in cardiac arrest. PULSELESS VENTRICULAR TACHYCARDIA.
I: Treat the METABOLIC ACIDOSIS that may accompany CARDIAC ARREST & the HYPERKALEMIA & ACIDOTIC STATES to specific drug overdose situations.4 mg-meterd dose. up to 3 sprays in 15 MORPHINE SULFATE ATROPINE SULFATE ISOPROTERENOL IV: 1mg diluted in 250 ml of 5% dextrose water or normal saline. CI: Hypoventilation. severe kidney insufficiency. at 2- . CO2. which form water. NaCl.SODIUM BICARBONATE A: Reverses metabolic acidosis neutralizes gastric acid. NITROGLYCERIN SL: 0.3-0.4 mg Translingual aerosol spray: 0. raises blood pH. Hypocalcaemia.
may repeat VERAPAMIL ( Isoptin ) IV: age & weight dependent dosages. repeat in 15 min at 0.5 mg/min over 18 h Cardiac arrest: 300 mg diluted in 20-30 ml D5W rapidly followed by continuous infusion as above. repeat DILTIAZEM ( Cardizel ) IV: 0. then 0.2 g/d . max: 2.25mg/kg. should not exceed 5mg.35 mg/kg AMIODARONE Adult IV with pulse: 150 mg over 10 min. then continuous infusion 1 mg/min for 6 h.ADENOSINE Adult IV: initially 6 mg then 12mg in 1-2 min if needed.
5 mg/kg.5-1 mg. may be repeated q 3-5 min VASOPRESSIN . may repear0. Give IV/IO in EPINEPHRINE IV/IO: 0.5 mg/kg q 5-10 min up to 3 mg/kg (max) ETT*: 2-4 mg/kg Child IV/IO: initially 1 mg/kg.LIDOCAINE Adult IV/IO: 1-1. maintenance 20-50 mcg/kg/min is PROCAINAMIDE MAGNESIUM SULFATE Dilute 1-2 g (2-4 ml of a 50% solution) in 10 ml of D5W.
METHYLPREDNISOLONE A: Reverses increased capillary permeability. EDEMA & INCREASED INTRACRANIAL Pregnancy. spinal cord injury more than 8 hour old. CAUTION: Hypo/Hpernatremia. current intracranial bleeding.SODIUM BICARBONATE MANNITOL A: Inhibition of reabsorption of electrolytes and water by affecting pressure of glomerular filtrate. I: An option to clients with TRAUMATIC SPINAL CORD INJURIES. penetrating trauma to the spinal cord. CI: Hypersensitivity. CI: Hypersensitivity. Pregnancy and uncontrolled DM. SE: Temporary volume expansion. severe dehydration. . breastfeeding. severe infection. HIV infection. I: Treat CEREBRAL PRESSURE.
I: Clients who have taken an OVERDOSE OF OPIATE DRUGS. & those brought to emergency department in a COMA of UNKNOWN ETIOLOGY. SE: No major side effects but ccan precipitate withdrawal symptoms and rarely cause anaphylaxis. then 5. those experiencing RESPIRATORY or CARDIOVASCULAR DEPRESSION from therapeutic doses of opiates given in health care setting. CI: Respiratory depression due to non-opioid drugs. .4 mg/kg/h (23 h) or 48 h NALOXONE ( Narcan ) A: May displace opiod analgesics from their receptors to reverse it effects.MANNITOL Adult IV: initially 1 g/kg of 20%-25% solution as a bolus High METHYLPREDNISOLONE IV bolus dose: 30 mg/kg in 100 ml NSS.
hemorrhage.5 mg over 30 sec every 1 min as indicated. ACTIVATED CHARCOAL I: To PREVENT ABSORPTION OF TOXINS INTO THE BODY .3-0. anatomically-broken GI tract. For re-sedation. GI perforation. SE: Vomiting. may be repeated at .FLUMAZENIL A: Inhibits the activity at the benzodiazepine receptor. I: Reversal agent RESPIRATORY DEPRESSANT & SEDATIVE EFFECTS OF BENZODIAZEPINE MEDICATIONS.2 mg over 15 sec. CI: Intestinal obstruction. CI: Hypersensitivity. NALOXONE FLUMAZENIL IV: initial dose 0. Additional doses of 0.
Dysrhythmias. CI: Patients with marked obstruction of cardiac ejection such as idiopathic hypertrophic subaortic stenosis. Headache. I: To treat HYPOTENSION IN SHOCK STATES not caused by HYPOVOLEMIA. Nausea . SE: Myocardial ischemia. CI: Patients with phaechromocytoma or hyperthyroidism. Nausea & Vomiting. DOBUTAMINE A: Causes mild vasodilation. Tachycardia. SE: Tachycardia. I: Enhances the force of MYOCARDIAL CONTRACTION & INCREASE HEART RATE. Myocardial ischemia.ACTIVATED CHARCOAL DOPAMINE A: Causes vasoconstriction. Dysrhythmias.
I: Used in SHOCK STATES. I: Treatment of ANAPHYLACTIC SHOCK. Anxiety. I: Reverse bronchoconstiction in ANAPHYLACTIC SHOCK. & COPD. Threatened abortion during the 1st or 2nd trimester. EPINEPHRINE A: Causes bronhodilation and vasoconstriction. SE: Excitability. & Restlessness ALBUTEROL A: Causes bronchodilation. Fear. CI: Hypersensitivity. .NOREPINEPHRINE A: A catecholamine with extremely potent vasoconstrictor actions. lactation. ASTHMA. CI: Not be used to teat hypotension in hypovolemic clients.
Confusion.DIPHENHYDRAMINE HYDROCHLORIDE A: Decreases allergic response by blocking histamine. SE: Drowsiness. Vertigo. CI: Hypersensitivity. Hypotension. DEXTROSE 50% I: To treat INSULIN-INDUCED HYPOGLYCEMIA or INSULIN SHOCK SE: Phlebitis . I: Effective for treating the HISTAMINE-INDUCED TISSUE SWELLING & PRURITUS common to severe allergic reactions. Sedation. History of sleep apnea. Excitability.
GLUCAGON A: A hormone produced from pancreas that elevates blood sugar by stimulating glycogen breakdown I: Treatment of SEVERE INSULIN-INDUCED HYPOGLYCEMIA or INSULIN SHOCK . CI: Phaeochromocytoma. hypersensitivity DOPAMINE Adult IV: drip 2-20 mcg/kg/min (>10 mcg/kg/min may be ordered if DOBUTAMINE NOREPINEPHRINE ALBUTEROL .
. I: Indicated for the acute management of clinically significant HYPERTENSION in the prescence of ISCHEMIC & HEMMORHAGIC STROKE. as well as for HYPERTENSIVE CRISIS.DIPHENHYDRAMINE HYDROCHLORIDE DEXTROSE 50% Adult IV: 50 ml GLUCAGON LABETALOL A: Inhibits the effects of the sympathetic nervous system. CI: Clients with bronchial asthma or COPD. severe bradycardia & apparent heart failure.
compensatory hypertension.. & Electrolyte disturbances. I: For ACUTE PULMONARY EDEMA from LEFT VENTRICULAR DYSFUNCTION & HYPERTENSIVE CRISIS. Dehydration. CI: Hypersensitivity. FUROSEMIDE A: Inhibits sodium & chloride reabsorption from the ascending loop of Henle and the proximal & distal tubules. I: To reduce ARTERIAL BLOOD PRESSURE in HYPERTENSIVE EMERGENCIES CI: Hypersensitivity. .NITROPRUSSIDE SODIUM A: It is immediate direct arterial and venous vasodilation. SE: Hypovolemia.
begin at 0. epilepsy. anastomoses. CI: Hypersensitivity. repeated or doubled q 10 min up NITROPRUSSIDE SODIUM Adult IV: drip 0. Hypotension.25 mcg/kg/min & titrate to FUROSEMIDE . pregnancy. I: For ACUTE PULMONARY EDEMA. LABETALOL IV: initial push 10-20 mg over 2 min. SE: Respiratory distress.25-5 mcg/kg/min.MORPHINE SULFATE A: Produces venous bronchodilation that decreases cardiac preload.
MORPHINE SULFATE .
This action might not be possible to undo. Are you sure you want to continue?